PharmGKB: Understanding the effects of individual genetic variants

Drug Metabolism Reviews

Volumn 40, Issue 4, 2008, Pages 539-551

  Sangkuhl, Katrin ^a   Berlin, Dorit S ^a   Altman, Russ B ^a,b   Klein, Teri E ^a  

^a STANFORD UNIVERSITY   (United States)

^b Stanford University   (United States)

Author keywords

Disease; Drug; Gene; Pharmacogenetics; Pharmacogenomics; PharmGKB; Polymorphism; Tamoxifen; Variant; Warfarin

Indexed keywords

TAMOXIFEN; WARFARIN;

DRUG RESPONSE; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; PHARMACOGENETICS; PHARMACOGENOMICS; PHENOTYPE; PROTEIN STRUCTURE; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM;

GENETIC VARIATION; HUMANS; INTERNET; PHARMACEUTICAL PREPARATIONS; PHARMACOGENETICS; PROTEIN STRUCTURE, SECONDARY; SIGNAL TRANSDUCTION;

EID: 54549125821     PISSN: 03602532     EISSN: 10979883     Source Type: Journal    
DOI: 10.1080/03602530802413338     Document Type: Review

References (18)

1. Berman, H., Henrick, K., Nakamura, H. (2003). Announcing the worldwide Protein Data Bank. Nat. Struct. Biol. 10(12):980.
2. Garten, Y., Altman, R. B. (2008). Pharmspresso: a text mining tool for extraction of pharmacogenetics concepts and relationships from full text. 2008 AMIA Translational Bioinformatics Summit: submitted.
3. Giacomini, K. M., Brett, C. M., Altman, R. B., Benowitz, N. L., Dolan, M. E., Flockhart, D. A., et al. (2007). The pharmacogenetics research network: from SNP discovery to clinical drug response. Clin. Pharmacol. Ther. 81(3):328-345.
4. Goetz, M. P., Knox, S. K., Suman, V. J., Rae, J. M., Safgren, S. L., Ames, M. M., et al., (2007). The impact of cytochrome P450 2D6 metabolism in women receiving adjuvant tamoxifen. Breast Cancer Res. Treat. 101(1):113-121.
5. Hernandez-Boussard, T., Whirl-Carrillo, M., Hebert, J. M., Gong, L., Owen, R., Gong, M., et al. (2008). The pharmacogenetics and pharmacogenomics knowledge base: accentuating the knowledge. Nucleic Acids Res. 36:D913-D918.
6. Hirakawa, M., Tanaka, T., Hashimoto, Y., Kuroda, M., Takagi, T., Nakamura, Y. (2002). Nucleic Acids Res. 30(1):158-162.
7. Hodge, A. E., Altman, R. B., Klein, T. E. (2007). The PharmGKB: integration, aggregation, and annotation of pharmacogenomic data and knowledge. Clin. Pharmacol. Ther. 81(1):21-24.
8. Jordan, V. C. (2008). Tamoxifen: catalyst for the change to targeted therapy. Eur. J. Cancer 44(1):30-38.
9. Karolchik, D., Kuhn, R. M., Baertsch, R., Barber G. P., Clawson, H., Diekhans, M., et al. (2008). The UCSC genome browser database: 2008 update. Nucleic Acids Res. 36:D773-D779.
10. Kent, W. J., Sugnet, C. W., Furey, T. S., Roskin, K. M., Pringle, T. H., Zahler, A. M., et al. (2002). The human genome browser at UCSC. Gen. Res. 12(6):996-1006.
11. International Wafarin Pharmacogenetics Consortium. (2008). Global Warfarin Pharmacogenetic Dosing Algorithm. submitted
12. Lindberg, D. A., Humphreys, B. L., McCray, A. T. (1993). The Unified Medical Language System. Meth. Inf. Med. 32:281-291.
13. Owen, R. P., Altman, R. B., Klein, T. E. (2008). PharmGKB and the International Warfarin Pharmacogenetics Consortium: the changing role for pharmacogenomic databases and single-drug pharmacogenetics. Hum. Mutat. 29(4):456-460.
14. Owen, R. P., Klein, T. E., Altman, R. B. (2007). The education potential of the pharmacogenetics and pharmacogenomics knowledge base (PharmGKB). Clin. Pharmacol. Ther. 82(4):472-475.
15. Poulter, G. M., Rubin, D. L, Altman, R. B., Seoighe, C. (2008). MScanner: a classifier for retrieving Medline citations. BMC Bioinform. 9:108.
16. Schroth, W., Antoniadou, L., Fritz, P., Schwab, M., Muerdter, T., Zanger, U. M., et al. (2007). Breast cancer treatment outcome with adjuvant tamoxifen relative to patient CYP2D6 and CYP2C19 genotypes. J. Clin. Oncol. 25(33):5187-5193.
17. Sherry, S. T., Ward, M. H., Kholodov, M., Baker, J., Phan, L., Smigielski, E. M., et al. (2001). dbSNP: the NCBI database of genetic variation. Nucleic Acids Res. 29(1):308-311.
18. Wain, H. M., Bruford, E. A., Lovering, R. C., Lush, M. J., Wright, M. W., Povey, S. (2002). Guidelines for human gene nomenclature. Genomics 79(4):464-470.